From Sydney to Boston: Why Harrison.ai Cut Local Jobs Despite a $32M Government Lifeline

Brothers Dr Aengus Tran [L] and Dimitry Tran founded Harrison.ai.

Homegrown AI medtech startup Harrison.ai has recently made headlines for laying off local staff and launching a dedicated US business, all less than two years after securing a massive $32 million government investment designed to anchor its operations in Australia.

The Rise of AI-Driven Workflows

Founded in 2018 by brothers Aengus and Dimitry Tran, Harrison.ai initially gained traction with AI tools for IVF embryo selection. Today, its flagship technology assists radiologists worldwide by analyzing CT scans and X-rays to detect medical conditions faster and more accurately. With products now deployed across 40+ countries and utilized by half of all Australian radiologists, the company has grown into a major player in the health-tech sector.

However, rapid growth brought internal changes. Earlier this year, Harrison.ai restructured its workforce, transitioning employees into “player-coach” roles where each team member now orchestrates a fleet of AI agents. This shift toward AI-first operations led to several redundancies in Australia, with some staff choosing to leave voluntarily as the company optimized its internal processes.

Strategic Expansion Beyond Borders

While domestic roles shifted, Harrison.ai aggressively pursued international markets. The startup recently launched Frontier Radiology, a US-based teleradiology service that pays clinicians to utilize Harrison.ai’s diagnostic platform. Headquartered in Boston, Frontier Radiology aims to deliver consistent, high-quality imaging reports to hospitals and health systems nationwide, positioning itself as the operational backbone for intelligent radiology.

This expansion follows a landmark funding round that valued the company at nearly $400 million, bolstered by the Australian government’s National Reconstruction Fund (NRF). At the time, NRF chair Martijn Wilder emphasized that the investment would guarantee Harrison.ai’s continued presence in Australia.

Navigating Scrutiny & Future Outlook

The company’s rapid commercialization hasn’t been without controversy. A late 2024 partnership with I-Med Radiology Network sparked debates over patient data privacy, as hundreds of thousands of medical scans were shared to train AI models. The Office of the Australian Information Commissioner (OAIC) conducted preliminary inquiries but ultimately closed the case, confirming that all shared data was properly de-identified and compliant with privacy laws.

In response to recent workforce changes, the NRF acknowledged the transition from product development to global commercialization. Officials noted that evolving skill requirements naturally reshape teams during scaling phases, while reaffirming strong confidence in Harrison.ai’s long-term trajectory and commitment to improving healthcare outcomes globally.